We are live on ! Find out more
MLAB icon

Mesa Laboratories

174 hedge funds and large institutions have $1.35B invested in Mesa Laboratories in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 4

14% more funds holding

Funds holding: 153174 (+21)

11% more capital invested

Capital invested by funds: $1.21B → $1.35B (+$135M)

0% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 59

1.68% less ownership

Funds ownership: 93.64%91.96% (-1.7%)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
174
Holders Change
+21
Holders Change %
+13.73%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
26
Increased
59
Reduced
59
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
GT
26
Glenmede Trust
Pennsylvania
$7.65M +$4.92M +17,873 +202%
PI
27
Putnam Investments
Massachusetts
$7.62M +$36K +131 +0.5%
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$7.41M -$18.7K -68 -0.3%
Morgan Stanley
29
Morgan Stanley
New York
$7.33M +$3.29M +11,945 +88%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$6.25M +$106K +386 +2%
FAM
31
Fred Alger Management
New York
$5.82M +$663K +2,410 +13%
Luther King Capital Management (LKCM)
32
Luther King Capital Management (LKCM)
Texas
$5.76M -$49.5K -180 -0.9%
Millennium Management
33
Millennium Management
New York
$5.42M +$728K +2,646 +16%
JP Morgan Chase
34
JP Morgan Chase
New York
$5.42M +$4.72M +17,140 +971%
Marshall Wace
35
Marshall Wace
United Kingdom
$5.3M -$568K -2,066 -10%
N
36
Nuveen
North Carolina
$5.01M +$152K +551 +3%
Bank of America
37
Bank of America
North Carolina
$5.01M +$142K +516 +3%
CRC
38
Catawba River Capital
South Carolina
$4.37M +$4.19M +15,232 New
RJFSA
39
Raymond James Financial Services Advisors
Florida
$4.08M +$143K +518 +4%
ORI
40
Oak Ridge Investments
Illinois
$4.06M -$903K -3,281 -19%
Renaissance Technologies
41
Renaissance Technologies
New York
$4.04M -$7.7M -28,000 -67%
Legal & General Group
42
Legal & General Group
United Kingdom
$3.95M -$17.3K -63 -0.5%
AllianceBernstein
43
AllianceBernstein
Tennessee
$3.92M -$35.8K -130 -0.9%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$3.83M +$256K +931 +7%
BG
45
Bahl & Gaynor
Ohio
$3.79M +$52K +189 +1%
Goldman Sachs
46
Goldman Sachs
New York
$3.53M -$17.7M -64,502 -84%
Citadel Advisors
47
Citadel Advisors
Florida
$3.47M +$1.89M +6,877 +132%
RJA
48
Raymond James & Associates
Florida
$3.24M +$165K +598 +6%
Swiss National Bank
49
Swiss National Bank
Switzerland
$3.15M +$82.5K +300 +3%
Public Sector Pension Investment Board (PSP Investments)
50
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.08M +$8.25K +30 +0.3%

MLAB Hedge Fund Activity: Q4 2020 in Review

174 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2020, worth a combined $1.35B — up 11% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new MLAB positions and 4 closed out — a net gain of 22 holders — while 59 added to existing stakes and 59 trimmed.

The largest buyer was BlackRock, adding an estimated $7.22M. The largest seller was Goldman Sachs, cutting an estimated $17.7M.

  • 174 institutional investors held Mesa Laboratories (MLAB) as of Q4 2020, up from 153 in Q3 2020.
  • Funds reported $1.35B of Mesa Laboratories stock for Q4 2020, up 11% quarter-over-quarter.
  • 26 funds opened new Mesa Laboratories positions in Q4 2020 and 4 closed out, a net change of +22 holders.
  • The largest Mesa Laboratories buyer in Q4 2020 was BlackRock, an estimated $7.22M added.
  • The largest Mesa Laboratories seller in Q4 2020 was Goldman Sachs, an estimated $17.7M sold.

Based on aggregated 13F filings for Q4 2020.